sharecast

{{ storiesRelated.title }}

Latest News
13:56
Watches of Switzerland shares surge on 'cautiously optimistic' outlook, Q4 sales

Shares in Watches of Switzerland surged 15% on Thursday as the luxury timepiece retailer said it was “cautiously optimistic” about future trading after a 4% rise in sales in the final quarter of its financial year driven by a strong performance in the US.

13:52
dl chevron corporation energy oil gas exploration production downstream us usa united states logo generic 1
Chevron preparing to sell UK North Sea oil and gas assets - report

Chevron is reportedly set to launch the sale of its remaining UK North Sea oil and gas assets, in a move that would mark the US energy firm’s exit from the ageing basin after more than 55 years.

13:50
Europe open: Stocks fall as ex-divs drag on corporate news

European shares were lower at the open as heavyweight stocks trading ex-dividend dragged on the benchmark Stoxx 600 index and investors digested US CPI data from Wednesday.

13:47
dl thames water water company ofwat tap water utility supplier logo 20231114 1241
Thames Water's biggest shareholder withdraws from board

Thames Water’s largest shareholder has withdrawn its representative from the crisis-hit utility's board, it was confirmed on Thursday.

12:54
dl facebook
EC launches formal probe into how Meta protects minors

The European Commission has launched formal proceedings to investigate whether Meta may have breached the Digital Services Act (DSA) through how it treats and protects minors on Facebook and Instagram.

12:49
dl nyse new york stock exchange wall st street city finance dow jones nasdaq sp finance dollar dollars us usa united states of america
US pre-open: Futures little changed as major indices hit record highs

Wall Street futures were slightly higher ahead of the bell on Thursday as cooler-than-expected inflation data helped push major indices to fresh record highs.

12:40
Angle reports promising results from Parsortix study

Angle, the AIM-listed liquid biopsy company which specialises in circulating tumour cell (CTC) solutions, has announced the results of a clinical study which show that its Parsortix system could be used to predict progression-free survival in patients with ovarian cancer.

12:10
dl redcentric aim red centric managed it service provider information technology digital computing logo
Redecentric FY earnings grow, four 'larger customers' unexpectedly cancel contracts

Cyber security firm Redcentric said on Thursday that both revenue and earnings had grown in the year ended 31 March but noted it had experienced installation delays at the London Technology Centre and contract cancellations by several large customers.

11:53
Europe midday: Shares down despite bullish Wall St, US data; Ex-divs weigh

European shares were lower as heavyweight stocks trading ex-dividend dragged on the benchmark Stoxx 600 index and investors digested US CPI data from Wednesday.

11:51
dl city of london generic river thames square mile finance 20240326 6
London midday: FTSE stays down as ex-divs weigh; Sage tumbles

London stocks were still a little weaker by midday on Thursday amid a deluge of corporate news, dragged lower by ex-dividend shares.

11:41
dl accsys technologies aim wood wooden building products developer technology logo
Accsys Technologies CFO departs after 13 months

AIM-listed Accsys Technologies has announced that its chief financial officer is leaving the wood products group after just a year in the role.

11:34
Japan GDP contracts more than expected, clouds BoJ rate plans

Japan’s economy unexpectedly shrank in the first quarter as consumers tightened their belts in response to stagnant wage growth, companies cut spending and exports fell.

11:29
dl city of london view high overview gherkin st mary axe offices towers buildings skyscrapers square mile financial district trading finance unsplash
US healthcare firm AOTI planning £160m London float - report

US woundcare technology developer AOTI is reportedly preparing to push the button on a London stock market flotation next month.

11:22
dl roche pharmaceuticals drugmaker europe logo generic 20231204 1350
Roche sees positive results from weight-loss trials

Roche reported positive trial results for its experimental weight loss treatment on Thursday, sending shares in the Swiss drugs group higher.

10:36
dl travis perkins building supplies construction products materials lorry truck delivery logo ftse 250
Barclays upgrades on Travis Perkins to 'overweight'

Barclays has raised its rating on builders merchant Travis Perkins from 'equal weight' to 'overweight', saying that the stock is an "undervalued UK recovery play".

10:35
dl japan japan exchange group jpx tokyo stock exchange nikkei 225 topix generic 1
Asia report: Markets rise despite deeper Japan GDP contraction

Asia-Pacific markets saw gains on Thursday, buoyed by Wall Street's record performance overnight driven by lower-than-expected inflation data in the US.

10:30
dl treatt plc food ingredients maker manufacturer beverage flavours producer logo
Berenberg lowers target price on Treatt, stays at 'buy'

Analysts at Berenberg cut their target price on food ingredients manufacturer Treatt from 700. 0p to 580. 0p on Thursday as its "slow start" to FY24 resulted in a downgrade to full-year revenue growth guidance.

10:17
dl water tap faucet ofwat water companies supply drinking water generic pb
Water Intelligence continues on 'solid growth trajectory'

Leak detection and remediation solutions provider Water Intelligence said on Thursday that its "solid growth trajectory" had continued over the three months ended 31 March in terms of both revenue and profits.

10:11
dl tullow oil energy oil and gas exploration development production logo
Tullow Oil on track to hit production and cash flow guidance

Tullow Oil has said it's on track to deliver full-year guidance and remains well placed to capitalise on a higher oil-price environment.

10:09
dl diaceutics aim diagnostics commercialisation pharmaceutical services medicine drugs testing logo
Diaceutics strikes two new enterprise-wide agreements

Technology and solutions provider Diaceutics has struck two new enterprise-wide agreements, taking the total number to six engagements, across 29 separate therapeutic brands.